• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估奥利万星对艰难梭菌孢子发芽、生长和复苏的影响。

Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.

机构信息

Leeds Institute for Molecular Medicine, University of Leeds, Leeds LS2 9JT, UK.

出版信息

J Antimicrob Chemother. 2013 Sep;68(9):2078-82. doi: 10.1093/jac/dkt160. Epub 2013 Jun 11.

DOI:10.1093/jac/dkt160
PMID:23759507
Abstract

OBJECTIVES

Previous work suggests oritavancin may be inhibitory to Clostridium difficile spores. We have evaluated the effects of oritavancin exposure on C. difficile spore germination, outgrowth and recovery.

METHODS

Germination and outgrowth of C. difficile spores exposed to different concentrations of oritavancin, vancomycin, or metronidazole (0.1-10 mg/L) were monitored at 0, 2, 4, 6, 24 and 48 h using phase-contrast microscopy. Recovery of antimicrobial-exposed spores was determined by viable counting on Brazier's modified CCEYL agar. Persistence of oritavancin activity on spores after washing was determined by measuring activity against a Staphylococcus aureus lawn.

RESULTS

Oritavancin, vancomycin and metronidazole exposure did not prevent germination of phase-bright spores to phase-dark spores, but did inhibit further outgrowth into vegetative cells. The inhibitory effect of oritavancin persisted after washing, whereas the inhibitory effects of vancomycin and metronidazole did not. Oritavancin exposure affected spore recovery; fewer spores were recovered after washing following oritavancin exposure than vancomycin exposure. The extent of this effect was dependent on PCR ribotype, with recovery of ribotype 078 spores completely prevented, but recovery of ribotype 001 spores only slightly affected. Spores exposed to oritavancin, but not vancomycin, retained antimicrobial activity after washing, indicating adherence of oritavancin, but not vancomycin, to the spore surface

CONCLUSIONS

Oritavancin may adhere to spores, potentially causing early inhibition of germinated cells, preventing subsequent vegetative outgrowth and spore recovery. This may prevent some recurrences of symptomatic C. difficile infection that are due to germination of residual spores following antibiotic therapy.

摘要

目的

先前的研究表明,奥他凡星可能对艰难梭菌孢子具有抑制作用。我们评估了奥他凡星暴露对艰难梭菌孢子发芽、生长和复苏的影响。

方法

使用相差显微镜在 0、2、4、6、24 和 48 小时监测不同浓度奥他凡星、万古霉素或甲硝唑(0.1-10 mg/L)暴露下艰难梭菌孢子的发芽和生长。通过在 Brazier 改良的 CCEYL 琼脂上进行活菌计数来确定暴露于抗菌药物的孢子的复苏情况。通过测量奥他凡星对金黄色葡萄球菌菌苔的活性来确定洗涤后奥他凡星活性在孢子上的持久性。

结果

奥他凡星、万古霉素和甲硝唑暴露不能阻止相亮孢子向相暗孢子的发芽,但确实抑制了进一步向营养细胞的生长。奥他凡星的抑制作用在洗涤后仍然存在,而万古霉素和甲硝唑的抑制作用则不存在。奥他凡星暴露影响孢子的复苏;与万古霉素暴露相比,洗涤后从奥他凡星暴露的孢子中回收的孢子较少。这种影响的程度取决于 PCR 核糖体型,核糖体型 078 孢子的复苏完全被阻止,但核糖体型 001 孢子的复苏仅受到轻微影响。暴露于奥他凡星但未暴露于万古霉素的孢子在洗涤后仍保留抗菌活性,表明奥他凡星而不是万古霉素与孢子表面结合。

结论

奥他凡星可能与孢子结合,可能导致发芽细胞的早期抑制,从而阻止随后的营养生长和孢子复苏。这可能防止了一些由于抗生素治疗后残留孢子发芽引起的有症状的艰难梭菌感染的复发。

相似文献

1
Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.评估奥利万星对艰难梭菌孢子发芽、生长和复苏的影响。
J Antimicrob Chemother. 2013 Sep;68(9):2078-82. doi: 10.1093/jac/dkt160. Epub 2013 Jun 11.
2
Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.奥他万古霉素不会诱导仓鼠或人类肠道模型中艰难梭菌的发芽和毒素产生。
J Antimicrob Chemother. 2012 Dec;67(12):2919-26. doi: 10.1093/jac/dks309. Epub 2012 Aug 16.
3
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.在人体肠道模型中,奥硝唑与万古霉素治疗克林霉素诱导的艰难梭菌PCR核糖体分型027感染的比较。
J Antimicrob Chemother. 2008 Nov;62(5):1078-85. doi: 10.1093/jac/dkn358. Epub 2008 Sep 4.
4
Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.非达霉素与艰难梭菌芽孢的关联:持续性对后续芽孢恢复、萌发及毒素产生的影响
PLoS One. 2016 Aug 24;11(8):e0161200. doi: 10.1371/journal.pone.0161200. eCollection 2016.
5
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.万古霉素在人体肠道模型中对流行艰难梭菌菌株的活性。
J Antimicrob Chemother. 2009 Mar;63(3):520-5. doi: 10.1093/jac/dkn502. Epub 2008 Dec 26.
6
Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model.利奈唑胺治疗复杂性腹腔内感染的疗效:一项随机、双盲、对照 III 期临床研究
J Antimicrob Chemother. 2012 Oct;67(10):2434-7. doi: 10.1093/jac/dks243. Epub 2012 Jun 21.
7
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.基因分型不同的艰难梭菌克隆菌株对奥硝唑的体外敏感性
J Antimicrob Chemother. 2008 Oct;62(4):762-5. doi: 10.1093/jac/dkn276. Epub 2008 Jul 7.
8
Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro.香芹酚在体外可减少艰难梭菌的孢子形成和孢子萌发。
J Med Microbiol. 2017 Aug;66(8):1229-1234. doi: 10.1099/jmm.0.000515. Epub 2017 Aug 8.
9
In vitro efficacy of sodium selenite in reducing toxin production, spore outgrowth and antibiotic resistance in hypervirulent Clostridium difficile.亚硒酸钠体外降低产毒、孢子萌发和高毒力艰难梭菌抗生素耐药性的效果
J Med Microbiol. 2019 Jul;68(7):1118-1128. doi: 10.1099/jmm.0.001008. Epub 2019 Jun 7.
10
Germination response of spores of the pathogenic bacterium Clostridium perfringens and Clostridium difficile to cultured human epithelial cells.致病性细菌产气荚膜梭菌和艰难梭菌孢子对培养的人上皮细胞的发芽反应。
Anaerobe. 2011 Apr;17(2):78-84. doi: 10.1016/j.anaerobe.2011.02.001. Epub 2011 Feb 12.

引用本文的文献

1
Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement.奥瑞他万星与达托霉素用于手术清创后骨髓炎治疗的比较
Infect Dis Ther. 2024 Mar;13(3):535-547. doi: 10.1007/s40121-024-00925-2. Epub 2024 Feb 29.
2
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment.一项表征艰难梭菌响应抗生素治疗时形态变化的实验方案。
J Vis Exp. 2017 May 25(123):55383. doi: 10.3791/55383.
3
A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection.
艰难梭菌感染的实验性和非标签疗法综述
Infect Dis Ther. 2017 Mar;6(1):1-35. doi: 10.1007/s40121-016-0140-z. Epub 2016 Dec 1.
4
The Synergistic Effect of High Pressure CO and Nisin on Inactivation of Spores in Aqueous Solutions.高压CO与乳酸链球菌素协同作用对水溶液中芽孢的灭活效果
Front Microbiol. 2016 Sep 21;7:1507. doi: 10.3389/fmicb.2016.01507. eCollection 2016.
5
Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.非达霉素与艰难梭菌芽孢的关联:持续性对后续芽孢恢复、萌发及毒素产生的影响
PLoS One. 2016 Aug 24;11(8):e0161200. doi: 10.1371/journal.pone.0161200. eCollection 2016.
6
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.艰难梭菌的抗药性和耐药性降低:对艰难梭菌感染的诱导、治疗和复发的潜在影响。
Antibiotics (Basel). 2015 Jul 10;4(3):267-98. doi: 10.3390/antibiotics4030267.
7
Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections.奥利万星:一种新型糖肽类抗生素,用于治疗革兰氏阳性感染。
Infect Dis Ther. 2016 Mar;5(1):1-15. doi: 10.1007/s40121-016-0103-4. Epub 2016 Feb 1.
8
Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.糖肽类抗生素在革兰阳性感染中的应用:比较综述。
Drugs. 2015 Dec;75(18):2073-95. doi: 10.1007/s40265-015-0505-8.
9
Clostridium difficile drug pipeline: challenges in discovery and development of new agents.艰难梭菌药物研发进程:新型药物发现与开发面临的挑战
J Med Chem. 2015 Jul 9;58(13):5164-85. doi: 10.1021/jm5016846. Epub 2015 Mar 30.
10
Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model.瑞莫拉宁对艰难梭菌孢子的捕获:体外模型中的活性
Antimicrob Agents Chemother. 2015 May;59(5):2525-30. doi: 10.1128/AAC.04853-14. Epub 2015 Feb 17.